Conversations with the HPTN

Dr. Chirenje is a professor of obstetrics and gynecology at the College of Health Science at the University of Zimbabwe in Harare. His main research interest is HIV prevention clinical trials in women with particular emphasis on microbicides and pre-exposure prophylaxis development and cervical cancer screening/treatment of pre-cancer lesions in low resource settings. He is also principal investigator for a large U.S. National Institutes of Health-funded HIV clinical trials unit (UZ-UCSF) that is executing clinical trials for four networks (ACTG, IMPAACT, MTN, HPTN). 

Louis Shackelford is a community education coordinator at the Harlem Prevention Center CRS in Harlem, New York. He is responsible for fostering partnerships with community-based organizations, serving as a liaison and conducting educational activities for the community around research and sexual health.

Charles Chasakara is the CTU Community Engagement Coordinator at the University of Zimbabwe-University of California San Francisco Clinical Trials Unit in Harare, Zimbabwe. Charles currently works on HPTN 076, HVTN 703/HPTN 081 and HPTN 082.

Nyaradzo Mavis Mgodi, (MBChB, MMed) is a histopathologist with 8 years of experience conducting HIV clinical trials in women of reproductive age in Harare, Zimbabwe, the home of the University of Zimbabwe-University of California San Francisco (UZ-UCSF) Collaborative Research Programme, a DAIDS Clinical Trials Unit (CTU). She is lead investigator for the HPTN 076 and HPTN 082 protocols in Harare. She is protocol co-chairperson for HVTN 703/HPTN 081 study, also known as Antibody Mediated Prevention (AMP).